Karachi, February 27, 2025 – Citi Pharma Limited has announced the successful completion of its first-ever export to the MENA (Middle East and North Africa) Region, marking a significant milestone in its international expansion strategy.
This achievement strengthens Citi Pharma’s global presence and opens new avenues for growth in international markets.
In a formal communication with the Pakistan Stock Exchange (PSX), Citi Pharma disclosed that the export order was secured based on the company’s FDA accreditation, which was previously announced on September 20, 2024. This certification has enhanced Citi Pharma’s credibility, paving the way for further expansion beyond domestic operations.
The total export value for this transaction amounts to EUR 560,000, with Citi Pharma having already received an advance payment of EUR 200,000. The company has now secured the remaining balance of EUR 360,000, successfully concluding this initial export deal.
Looking ahead, Citi Pharma has ambitious plans to expand its footprint in international markets. The company aims to achieve an annual export value of at least EUR 8 million to EUR 10 million to the MENA Region, while also targeting similar figures in other global markets. These projections highlight Citi Pharma’s commitment to becoming a key player in the pharmaceutical export industry.
The completion of this export order represents a crucial step forward for Citi Pharma, as it continues to diversify its revenue streams and enhance its operational scale. By leveraging its FDA accreditation and strengthening its supply chain, Citi Pharma is positioning itself as a reliable and competitive exporter in the pharmaceutical sector.
This strategic move not only reinforces Citi Pharma’s credibility but also sets the foundation for further collaborations and partnerships in the MENA Region and beyond. The company remains focused on innovation, quality, and expanding its international reach to drive sustainable growth.
With this successful export transaction, Citi Pharma has demonstrated its ability to meet international standards and fulfill large-scale orders, ensuring a strong foothold in the global pharmaceutical market. As Citi Pharma continues to build its international presence, stakeholders can anticipate further developments that will solidify its reputation as a leading pharmaceutical exporter.
